Form 8 (OPD) Primary Health Properties PLC | 11-Jun-2025 | 15:30 | RNS |
Form 8.3 - Primary Health Properties plc | 11-Jun-2025 | 15:25 | Business Wire |
Form 8.3 - Assura plc | 11-Jun-2025 | 15:25 | RNS |
Form 8.3 - Primary Health Properties plc | 11-Jun-2025 | 15:20 | RNS |
Form 8.3 - Primary Health Properties Plc | 11-Jun-2025 | 14:59 | GlobeNewswire NA |
Statement regarding offer by PHP for Assura | 11-Jun-2025 | 14:55 | RNS |
Form 8.3 - The Vanguard Group, Inc.: Primary Hea... | 11-Jun-2025 | 14:41 | EQS Group |
Form 8.3 - Primary Health Properties PLC | 11-Jun-2025 | 14:25 | Business Wire |
Form 8.3 - PRIMARY HEALTH PROPERTIES PLC | 11-Jun-2025 | 13:20 | RNS |
Form 8.5 (EPT/RI) Primary Health Prop Replacement | 11-Jun-2025 | 12:33 | RNS |
Form 8.5 (EPT/RI) Primary Health Properties Plc | 11-Jun-2025 | 12:00 | RNS |
Form 8.3 - Primary Health Properties plc | 11-Jun-2025 | 11:55 | RNS |
Form 8.3 - Primary Health Properties plc | 11-Jun-2025 | 11:54 | RNS |
Form 8.3 - Assura plc | 11-Jun-2025 | 11:54 | RNS |
Form 8.3 - Primary Health Properties plc | 11-Jun-2025 | 11:48 | RNS |
Currency | UK Pounds |
Share Price | 102.80p |
Change Today | 2.85p |
% Change | 2.85 % |
52 Week High | 103.60 |
52 Week Low | 86.15 |
Volume | 6,893,328 |
Shares Issued | 1,336.49m |
Market Cap | £1,373.92m |
Beta | 0.01 |
RiskGrade | 84 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 6 |
Latest | Previous | |
---|---|---|
Q2 | Q1 | |
Ex-Div | 27-Mar-25 | 09-Jan-25 |
Paid | 09-May-25 | 21-Feb-25 |
Amount | 1.77p | 1.77p |
Time | Volume / Share Price |
15:28 | 107 @ 102.90p |
15:27 | 15,000 @ 102.97p |
15:26 | 754 @ 102.80p |
15:25 | 5 @ 103.00p |
15:25 | 1,000 @ 102.87p |
CFO | Richard Howell |
CEO | Mark Davies |
You are here: research